Gedeon Richter and Mithra Pharmaceuticals have added several “key markets” in Latin America to a licensing deal for the in-development Estelle (estetrol/drospirenone) 15mg/3mg oral contraceptive that Richter has already licensed for Europe and Russia.
Richter And Mithra Extend Estelle To Latin America
Firms Add Chile, Colombia, Ecuador, Mexico And Peru To Partnership
Gedeon Richter and Mithra have expanded their partnership on an in-development contraceptive, Estelle, to cover several Latin American territories on top of Europe and Russia.
